Hands That Tingle or Go Numb? Neuropathy Treatment Options, Explained

It usually begins at night: feet burning on top of the blanket, or fingers that cannot feel a shirt button. A doctor uses the word "neuropathy", hands over a leaflet about nerve pain, and the appointment ends. Then the searching starts — and it quickly runs into two very different worlds. One world offers careful, evidence-based care that mostly works by addressing why the nerves are damaged. The other sells injections, infusions and "nerve regeneration" packages. Understanding which world a treatment belongs to starts with one question: why are the nerves damaged in the first place?

Neuropathy is a symptom with many causes

Peripheral neuropathy means the nerves outside the brain and spinal cord are damaged or malfunctioning. The pattern and the treatment both depend on the cause. Diabetes is by far the most common — chronically high blood sugar slowly injures the longest nerves, which is why feet go first. But the list is long: vitamin B12 deficiency, excessive alcohol, thyroid disease, autoimmune conditions, chemotherapy, some infections, kidney disease, and inherited conditions. A significant share of cases remain "idiopathic" — no cause found even after thorough work-up. That diagnosis matters, because a treatable cause found early (B12 deficiency is the classic example) can stop or even reverse the damage, while an untreated cause keeps injuring the nerves no matter what else you try.

What treatment actually targets

• The cause, first. Tight diabetes control, B12 replacement, reduced alcohol, treating thyroid or autoimmune disease — this is the step that changes the disease's direction.
• Symptom control for the pain: nerve-pain medications such as gabapentin, pregabalin and duloxetine, chosen and dosed by a physician. These are not opioids and are not habit-forming in the way people fear.
• Physical measures: exercise and balance training, well-fitted footwear, daily foot checks for anyone with diabetes, and fall prevention. Nerves that cannot report injuries make wounds dangerous.
• Practical aids where useful: TENS units, capsaicin cream, and care at night with bedding that does not press on painful feet.

Where stem cell therapy fits — honestly

Nerve repair is one of the most tantalising ideas in regenerative medicine, because damaged peripheral nerves can regrow slowly in principle. That is why cell therapy research exists here: most human studies so far have focused on diabetic peripheral neuropathy, testing whether mesenchymal stromal cell therapy can improve blood flow and nerve function in the legs and feet. These studies are early-phase, small, and their results are mixed — some report modest improvements in sensation or nerve conduction measures, others find no meaningful benefit. No cell therapy is approved as a treatment for peripheral neuropathy in any major regulatory system. Anyone promising nerve regeneration in a commercial clinic is well ahead of the evidence.

Red flags in neuropathy clinics

• "Nerve regeneration" or "curing" neuropathy offered as an expected outcome, especially without identifying the cause first.
• No blood tests or work-up for B12, thyroid, glucose or alcohol use before proposing an expensive injection.
• Stem cell or PRP packages priced before anyone has examined the nerve study results (electromyography and nerve conduction tests).
• No neurologist involved, and pressure to commit on the spot.

Questions to ask before considering any injection or infusion

• Which cause of my neuropathy has been confirmed, and how is it being treated?
• Which published human study supports this exact treatment for my type of neuropathy?
• How will we measure improvement — sensation testing, nerve conduction studies, pain scores?
• What happens if it does not work, and what is the total cost?
• Will my own neurologist remain involved in my care?

The honest bottom line on neuropathy treatment

Neuropathy treatment works best when it is unglamorous: find the cause, treat it hard, protect the feet, and manage the pain with properly dosed medication and movement. Cell therapy for diabetic neuropathy is a genuine research direction, but it is early, small-scale, and unapproved — not a solution anyone should be sold before their diabetes, B12 or other underlying cause has even been addressed. The patients who improve most are usually the ones whose underlying cause was found and treated, which is exactly the step the expensive shortcuts skip.